Back
Edwards Lifesciences Quote, Financials, Valuation and Earnings
Sponsored
EW
Sponsored
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftly
Sell
38
EW
Edwards Lifesciences
Last Price:
86.46
Seasonality Move:
8.36%
7 Day Trial
ALL ACCESS PASS
$
7
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right hereEdwards Lifesciences Price Quote
$86.46
+0.03 (+-1.76%)
(Updated: April 27, 2024 at 6:03 AM ET)
Edwards Lifesciences Key Stats
Sell
38
Edwards Lifesciences (EW)
is a Sell
Day range:
$84.71 - $88.38
52-week range:
$60.57 - $96.12
Dividend yield:
0%
P/E ratio:
37.58
P/S ratio:
8.77
P/B ratio:
7.82%
Volume:
5M
Avg. volume:
3.3M
1-year change:
-1.12%
Market cap:
$52B
Revenue:
$6B
EPS:
$2.3
How Much Does Edwards Lifesciences Make?
-
How Much Are Edwards Lifesciences's Sales Annually?
EW Revenues are $6B -
How Much Profit Does Edwards Lifesciences's Make A Year?
EW net income is $1.4B
Is Edwards Lifesciences Growing As A Company?
-
What Is Edwards Lifesciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.14% -
What Is Edwards Lifesciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.06%
Edwards Lifesciences Stock Price Performance
-
Did Edwards Lifesciences Stock Go Up Last Month?
Edwards Lifesciences share price went down by -7.48% last month -
Did EW's Share Price Rise Over The Last Year?
EW share price fell by -1.12% over the past 1 year
What Is Edwards Lifesciences 52-Week High & Low?
-
What Is Edwards Lifesciences’s 52-Week High Share Price?
Edwards Lifesciences has traded as high as $96.12 over the past 52 weeks -
What Is Edwards Lifesciences’s 52-Week Low Share Price?
Edwards Lifesciences has traded as low as $60.57 over the past 52 weeks
Edwards Lifesciences Price To Free Cash Flow
-
Is Edwards Lifesciences Stock Overvalued?
Edwards Lifesciences is trading at a price to free cash flow ratio of 83.67 -
Is Edwards Lifesciences Stock Undervalued?
Edwards Lifesciences EV to Free Cash Flow ratio is 81.00 -
What Is Edwards Lifesciences’s Price Earnings Growth Ratio?
EW PEG ratio is 0.00 -
Is Edwards Lifesciences Trading At A Premium To Earnings?
Edwards Lifesciences EV to EBIT ratio is 31.56
Is It Risky To Buy Edwards Lifesciences?
-
How Much Debt Does Edwards Lifesciences Have?
Total long term debt quarterly is $597M -
How Much Cash Does Edwards Lifesciences Have?
Cash and short term investments quarterly total is $1.6B -
What Is Edwards Lifesciences’s Book Value Per Share?
Book value per share is 11.06
Is Edwards Lifesciences Cash Flow Positive?
-
What Is EW Cash Flow From Operations?
Cash flow from operations (TTM) is $895.8M -
What Is Edwards Lifesciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$711M -
What Is Edwards Lifesciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is $173.8M
Edwards Lifesciences Return On Invested Capital
-
Is Management Doing A Good Job?
EW return on invested capital is 20.18% -
What Is Edwards Lifesciences Return On Assets?
ROA measures how assets are converting to revenues and is 15.69% -
What Is EW Return On Equity?
ROE is a measure of profitability and is 22.08%
Edwards Lifesciences Earnings Date & Stock Price
-
What Is Edwards Lifesciences's Stock Price Today?
A single share of EW can be purchased today for 86.43 -
What Is Edwards Lifesciences’s Stock Symbol?
Edwards Lifesciences trades on the S&P500 under the ticker symbol: EW -
When Is Edwards Lifesciences’s Next Earnings Date?
The next quarterly earnings date for Edwards Lifesciences is scheduled on July 26, 2024 -
When Is EW's next ex-dividend date?
Edwards Lifesciences's next ex-dividend date is April 27, 2024 -
How To Buy Edwards Lifesciences Stock?
You can buy Edwards Lifesciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Edwards Lifesciences Competitors
-
Who Are Edwards Lifesciences's Competitors?
Below is a list of companies who compete with Edwards Lifesciences or are related in some way:
Edwards Lifesciences Dividend Yield
Data Unavailable
Edwards Lifesciences Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -6.15% | 2.79% |
Revenue: | 13.78% | 1.68% |
Analyst Recommendations
Buy Recommendations: | 11 |
---|---|
Hold Recommendations: | 15 |
Sell Recommendations: | 1 |
Price Target: | 94.66 |
Upside from Last Price: | 9.52% |